ImageneBio, Inc. (IMA) Form 8-K Material Events
ImageneBio, Inc. (IMA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IMA
CIK: 1835579
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerOusmane Caba
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-17 | 2026-08-14 | 4 Filing | 0001803794-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | 4 Filing | 0002064348-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002168 | View SEC Doc Filr Page |
| EFFECT | 2026-08-11 | — | EFFECT Filing | 9999999995-26-002625 | View SEC Doc Filr Page |
| EFFECT | 2026-08-11 | — | EFFECT Filing | 9999999995-26-002624 | View SEC Doc Filr Page |
| EFFECT | 2026-08-06 | — | EFFECT Filing | 9999999995-26-002555 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | S-8 | 0001193125-26-335229 | View SEC Doc Filr Page |
| S-3 | 2026-08-05 | — | S-3 | 0001193125-26-335213 | View SEC Doc Filr Page |
| POS AM | 2026-08-05 | — | POS AM | 0001193125-26-335203 | View SEC Doc Filr Page |
| 424B3 | 2026-08-05 | — | 424B3 | 0001193125-26-335180 | View SEC Doc Filr Page |
| S-3 | 2026-08-05 | — | S-3 | 0001193125-26-335163 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-333920 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-333912 | View SEC Doc Filr Page |
| 3 | 2026-07-28 | 2026-07-20 | 3 Filing | 0002064348-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-25 | 4 Filing | 0001803794-26-000002 | View SEC Doc Filr Page |
| 424B3 | 2026-07-23 | — | 424B3 | 0001193125-26-314180 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-20 | 8-K | 0001193125-26-314167 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 Filing | 0002126940-26-000004 | View SEC Doc Filr Page |
| 424B3 | 2026-06-29 | — | 424B3 | 0001193125-26-286817 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-22 | 8-K | 0001193125-26-285424 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001555242-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001361712-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001246530-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001572451-26-000005 | View SEC Doc Filr Page |
| 424B3 | 2026-06-17 | — | 424B3 | 0001193125-26-274147 | View SEC Doc Filr Page |